Table 1.

Baseline characteristics

Baseline CharacteristicsPatientsControlsP values
Severe Acute Respiratory Syndrome Coronavirus 2 +/Kidney Transplant Recipients, N=32Severe Acute Respiratory Syndrome Coronavirus 2 +/Nonkidney Transplant Recipients, N=3181Severe Acute Respiratory Syndrome Coronavirus 2 −/Kidney Transplant Recipients, N=224Severe Acute Respiratory Syndrome Coronavirus 2 −/Nonkidney Transplant Recipients, N=28,103P1P2P3
Age (yr), median (IQR)61.5 (55.5–65.5)65 (51–79)59.5 (47–67)59 (37–74)0.180.220.44
Female, n (%)14 (44)1611 (51)107 (48)16,403 (58)0.440.670.09
Black, n (%)18 (56)825 (26)53 (24)4406 (16)<0.001<0.001<0.001
BMI (kg/m2), median (IQR)28.2 (23.8–30.7)28.5 (24.4–33.9)27.9 (23.3–32.3)28.3 (24.2–33.3)0.430.930.58
Obesity, n (%)13 (41)1033 (32)87 (39)7552 (27)0.330.850.08
CHF, n (%)15 (47)697 (22)83 (37)5680 (20)0.0010.29<0.001
Alcohol abuse, n (%)3 (9)287 (9)20 (9)3700 (13)0.950.930.53
CPD, n (%)10 (31)1028 (32)69 (31)8894 (32)0.900.960.96
Baseline eGFR, median (IQR)37.4 (29.1–58.1)76.8 (51.6–98.1)31.5 (12.9–53.5)79.6 (56.3–100.3)<0.0010.07<0.001
Diabetes mellitus, n (%)25 (78)1254 (39)129 (58)7335 (26)<0.0010.03<0.001
Hypertension, n (%)31 (97)2050 (64)218 (97)15,099 (54)<0.0010.88<0.001
Liver disease, n (%)12 (38)343 (11)68 (30)3846 (14)<0.0010.42<0.001
Malignancy, n (%)3 (9)360 (11)39 (17)4347 (15)0.730.250.34
Stroke, n (%)7 (22)207 (7)19 (8)1659 (6)0.0010.02<0.001
Elixhauser score, median (IQR)10 (8–13.5)5 (2–9)10 (7–13)4 (1–8)<0.0010.33<0.001
Length of hospital stay (d), median (IQR)10.2 (6.6–25.7)7.9 (4.1–14.9)4.8 (3.2–8.2)3.3 (2.1–6.1)0.01<0.001<0.001
  • P values were obtained using the Kruskal Wallis test. Values in red represent statistically significant differences. P1 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–positive non-KTR, P2 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–negative KTR, P3 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–negative non-KTR. IQR, interquartile range; BMI, body mass index; CHF, congestive heart failure; CPD, chronic pulmonary disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; KTR, kidney transplant recipient.